Igm Biosciences Inc (IGMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2020 | 03-2020 | 12-2019 | 09-2019 | 06-2019 | |
| Operating Expenses | 19,407 | 18,573 | 15,937 | 10,673 | 10,531 |
| Operating Income | -19,407 | -18,573 | -15,937 | -10,673 | -10,531 |
| Other Income | 568 | 949 | 1,122 | 501 | -145 |
| Pre-tax Income | -18,839 | -17,624 | -14,815 | -10,172 | -10,676 |
| Net Income Continuous | -18,839 | -17,624 | -14,815 | -10,172 | -10,676 |
| Net Income | $-18,839 | $-17,624 | $-14,815 | $-10,172 | $-10,676 |
| EPS Basic Total Ops | -0.62 | -0.58 | 33.55 | -2.41 | -19.08 |
| EPS Basic Continuous Ops | -0.62 | -0.58 | 33.54 | -2.41 | -19.06 |
| EPS Diluted Total Ops | -0.62 | -0.58 | 33.55 | -2.41 | -19.08 |
| EPS Diluted Continuous Ops | -0.62 | -0.58 | 33.54 | -2.41 | -19.06 |
| EBITDA(a) | $-19,216 | $-18,657 | $-16,010 | $-10,568 | $-10,386 |